Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.15
Bid: 1.10
Ask: 1.20
Change: 0.00 (0.00%)
Spread: 0.10 (9.091%)
Open: 1.15
High: 1.15
Low: 1.15
Prev. Close: 1.15
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting and Directorate Change

8 Mar 2021 13:30

RNS Number : 5245R
Chamberlin PLC
08 March 2021
 

8 March 2021

 

Chamberlin plc

(the "Company" or the "Group")

 

Result of General Meeting, Issue of Equity, Directorate Change and Corporate Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and engineering group, is pleased to announce the following updates:

 

Result of General Meeting, Issue of Equity and Total Voting Rights

 

All resolutions put to shareholders at the Company's General Meeting held earlier today, were duly passed on a poll. The poll results were as follows:

 

Resolution

For

%

Against

%

Withheld

1

3,769,484

99.34

25,005

0.66

542

2

3,769,484

99.34

25,005

0.66

542

3

3,769,174

99.33

25,315

0.67

542

4

3,769,484

99.34

25,005

0.66

542

Note: A vote "Withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "For" and "Against" shown.

 

As detailed in the circular issued by the Company on 19 February 2021 (the "Circular"), following completion of the Share Capital Reorganisation, each Existing Ordinary Share of 25p has been sub-divided into one Ordinary Share of 0.1 pence and one Deferred Share of 24.9 pence.

 

In addition, the Company announced that it had received on 19 February 2021, new funding of £200,000 from Mr Trevor Brown by way of an unsecured convertible loan note instrument to help support the short-term working capital requirements of the Company, resulting in Trevor Brown being issued with £200,000 Notes. Following the passing of the Resolutions, the Notes have automatically converted into 3,333,333 New Ordinary Shares (at a Conversion Price of 6.0 pence per New Ordinary Share) and following Admission, Trevor Brown will hold 3,333,333 Ordinary Shares representing 29.52 per cent. of the Company's issued share capital.

 

Application has been made for the New Ordinary Shares of 0.1p each to be admitted to trading on AIM. It is expected that Admission will become effective and that dealings in the New Ordinary Shares will commence on 9 March 2021. For the avoidance of doubt, the current suspension of trading of the Existing Ordinary Shares on AIM will not be lifted by the London Stock Exchange as a result of Admission.

 

Following Admission, the total number of Ordinary Shares of 0.1p each in the capital of the Company in issue will be 11,291,459 with each Ordinary Share carrying the right to one vote. There are no ordinary shares held in treasury and therefore the total number of voting rights in the Company is 11,291,459. The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Directorate Change

 

Further to the announcement dated 19 February 2021, the Board is pleased to announce the appointment of Trevor Brown as a non-executive director with immediate effect.

Trevor Brown has been a strategic investor in real estate and equities for more than 30 years. Trevor Brown has worked as a director in a number of businesses over many years and is currently CEO of IQ-AI Limited, CEO of Braveheart Investment Group plc and a non-executive director of Remote Monitored Systems plc. He was previously a director of Feedback plc, Management Resource Solutions plc and Advanced Oncotherapy plc.

 

Trevor Edward Brown, aged 74, currently holds or has held the following directorships and partnerships in the last five years:

 

Current directorships/partnerships

Past directorships/partnerships

Braveheart Investment Group plc

Braveheart Nominees Ltd

Braveheart Academic Seed Funding GP Ltd

Caledonia LP Ltd

Caledonia Portfolio Realisations Ltd

Feedback plc

Free Association Books Limited

Management Resource Solutions plc (in liquidation)

Free Publishing Ltd

Peterhouse Capital Limited

IQ-AI Ltd

Prostate Checker Ltd

Kirkstall Ltd

Remote Monitored Systems plc

Paraytec Ltd

Strat Aero International Limited

Ridings Holdings Ltd

Strathclyde Innovation Fund GP Ltd

Stone Checker Software Ltd

The Ridings Early Growth Investment Company Ltd

 

There are no further disclosures to be made pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

Corporate Update

 

As previously reported, the Board has been rigorously investigating the possibility of new equity capital and alternative measures to ensure the Company's future. After evaluating all current options with its advisers, the Board was of the opinion that the initial funding by Trevor Brown under the Notes represented the best short-term opportunity. Given Trevor Brown's experience, the Board believe his appointment as a non-executive director will be significantly beneficial and help maximise the ability to exploit all other avenues of funding which might be available to the Group.

 

The Board continues to explore all other funding possibilities, which if secured, the Board believes will demonstrate to the Company's auditor (and creditors, including HSBC), that the Company is able to continue to trade on a going concern basis in order to be able to publish and file its annual audited accounts for the year end 31 March 2020, publish its interim results for the six months ended 30 September 2020 and apply for the suspension of trading of the Existing Ordinary Shares on AIM to be lifted by the London Stock Exchange.

 

Further announcements will be made, as appropriate.

 

Terms defined in the Circular dated 19 February 2021 apply throughout this announcement, unless the context requires otherwise.

 

Enquiries:

 

Chamberlin plc

Kevin Nolan, Chief Executive

Neil Davies, Finance Director

T: 01922 707100

 

Cenkos Securities plc (Nominated Adviser and Broker)

Russell Cook

Katy Birkin

T: 020 7397 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFVVRITIIL
Date   Source Headline
22nd Apr 20247:00 amRNSHolding(s) in Company
16th Apr 202410:43 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTrading Update
5th Apr 20247:00 amRNSBoard Changes
3rd Apr 20244:12 pmRNSHolding(s) in Company
27th Feb 20241:24 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSCompletion of Sale of Petrel Limited
21st Feb 202412:01 pmRNSSale of Petrel Limited
21st Feb 202412:00 pmRNSInterim Results
18th Jan 20243:34 pmRNSHolding(s) in Company
16th Jan 20241:20 pmRNSHolding(s) in Company
11th Jan 20246:26 pmRNSHolding(s) in Company
10th Jan 20245:12 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSPlacing and Subscription
3rd Jan 20242:41 pmRNSResult of AGM and Trading Update
15th Dec 20237:00 amRNSCorporate Update
30th Nov 20231:40 pmRNSFinal Results
28th Nov 20235:00 pmRNSHolding(s) in Company
24th Oct 20234:22 pmRNSChange of Nominated Adviser and Joint Broker
18th Oct 20232:14 pmRNSHolding(s) in Company
27th Jul 20232:00 pmRNSGrant of Share Options
24th Jul 202310:17 amRNSDirector/PDMR Shareholding
22nd Jun 20232:03 pmRNSMajor Contract Win
8th Jun 20237:00 amRNSHolding(s) in Company
26th May 20237:00 amRNSPlacing and Subscription
2nd May 20233:42 pmRNSSale and Leaseback of Walsall Property
28th Feb 20237:00 amRNSHalf-year Report
2nd Feb 20234:14 pmRNSHolding(s) in Company
1st Feb 20235:24 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSHolding(s) in Company
26th Jan 202311:53 amRNSPlacing and Subscription
19th Dec 202211:00 amRNSHolding(s) in Company
16th Dec 20221:49 pmRNSCorporate Update
30th Nov 202211:37 amRNSResult of AGM
30th Nov 20227:00 amRNSAGM Statement and Trading Update
21st Nov 20222:44 pmEQSChamberlin PLC 'left no stone unturned' during return to profit
7th Nov 20225:31 pmRNSPosting of Annual Report and Notice of AGM
4th Nov 202212:23 pmRNSFinal Results
31st Oct 202211:32 amRNSAnnouncement re: Full year results
29th Sep 20227:00 amRNSAnnouncement re: Full year results
29th Jul 20227:00 amRNSIssue of Equity and Director/PDMR Shareholding
25th Jul 20225:30 pmRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 20225:20 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSFull Year Trading Update and Notice of Results
8th Jun 20229:42 amRNSDirector/PDMR Shareholding
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.